Abstract:Lnc00113 is highly expressed in triple‐negative breast cancer. Lnc00113 can regulate NOB1 expression by competitively adsorbing NOB1 mRNA with miR‐107 and promoting tumor progression through the NOB‐1/MAPK axis. Background Triple‐negative breast cancer (TNBC) represents the most aggressive form of breast cancer. While the involvement of long non‐coding RNA (lncRNA) in the progression of TNBC has been demonstrated, the role of Lnc00113 in TNBC remains unexplored. We aimed to explore the function of Lnc00113 in TNBC. Methods Expression levels and the clinical significance of Lnc00113 were assessed in The Cancer Genome Atlas (TCGA) database. The expression levels of Lnc00113 in TNBC tissues and cell lines were examined using qRT‐PCR (quantitative Real‐Time Polymerase chain reaction). The proliferation, apoptosis and invasion abilities were evaluated using CCK‐8 (Cell Counting Kit‐8), EdU (5‐Ethynyl‐2'‐deoxyuridine), apoptosis and transwell assays following Lnc00113 knockdown/overexpression. Dual‐luciferase and fluorescence in situ hybridization assays were employed to detect the correlation between Lnc00113, miR‐107 and Nin‐one binding protein (NOB‐1). Results We identified significant upregulation of Lnc00113 in TNBC tissues and cell lines, with high Lnc00113 expression correlating with advanced pathological staging and poorer prognosis in the TCGA database. Functional assessments through knockdown/overexpression experiments revealed that Lnc00113 promoted TNBC cell proliferation, apoptosis and invasion. Fluorescence in situ hybridization experiments showed cytoplasmic localization of both Lnc00113 and NOB‐1. Dual‐luciferase assays demonstrated direct binding between Lnc00113 and miR‐107, while miR‐107 directly interacted with NOB‐1. Mechanistically, our findings indicated that Lnc00113 promotes TNBC progression through the miR‐107/NOB‐1/MAPK signaling axis. Conclusion Lnc00113 emerges as a potential driver of TNBC growth and progression through modulation of the NOB‐1/MAPK signaling axis, providing insights into diagnostic biomarkers and therapeutic targets for TNBC.

LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC

Long Noncoding RNA SNHG14 Promotes Breast Cancer Cell Proliferation and Invasion Via Sponging Mir-193A-3p

LncRNA NRON Promotes the Proliferation, Metastasis and EMT Process in Bladder Cancer

LINC00668 silencing retards tumorigenesis via sponging miR-518c-3p to regulating WDR1 in triple negative breast cancer

ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer

Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness

Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p

LncRNA NRON promotes tumorigenesis by enhancing MDM2 activity toward tumor suppressor substrates

Lnc00113 promotes triple‐negative breast cancer progression via the NOB‐1/MAPK signaling axis

LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis

HNRNPU Promotes the Progression of Triple-Negative Breast Cancer Via RNA Transcription and Alternative Splicing Mechanisms.

An in Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression

Long Non-Coding RNA NRON promotes Tumor Proliferation by regulating ALKBH5 and Nanog in Gastric Cancer

LINC01503 promotes the cell proliferation, migration and invasion of triple-negative breast cancer as a ceRNA to elevate SPNS2 expression by sponging miR-335-5p

LINC00514 upregulates CCDC71L to promote cell proliferation, migration and invasion in triple‐negative breast cancer by sponging miR-6504-5p and miR-3139

Upregulation of Small Nucleolar RNA 78 Promotes Cell Proliferation and Invasion of Breast Cancer

Long non-coding RNA ROR recruits histone transmethylase MLL1 to up-regulate TIMP3 expression and promote breast cancer progression

Prognostic Value of Long Non-Coding RNAs in Triple Negative Breast Cancer

LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication

Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells

Long noncoding RNA profiling unveils LINC00960 as unfavorable prognostic biomarker promoting triple negative breast cancer progression